• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?

作者信息

Einhorn Lawrence H, Adra Nabil, Hanna Nasser, Nichols Craig

机构信息

Lawrence H. Einhorn, MD; Nabil Adra, MD; and Nasser Hanna, MD, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; and Craig Nichols, MD, SWOG Chair's Office and Testicular Cancer Commons, Portland, OR.

出版信息

J Clin Oncol. 2020 Sep 10;38(26):3073-3074. doi: 10.1200/JCO.20.00702. Epub 2020 Jul 7.

DOI:10.1200/JCO.20.00702
PMID:32634334
Abstract
摘要

相似文献

1
Adjuvant Etoposide Plus Cisplatin for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumors: Is This the Preferred Option?
J Clin Oncol. 2020 Sep 10;38(26):3073-3074. doi: 10.1200/JCO.20.00702. Epub 2020 Jul 7.
2
Primum non nocere: do we harm stage I testicular cancer patients less by applying adjuvant chemotherapy than by failing to present this option?
Ann Oncol. 2015 Feb;26(2):255-6. doi: 10.1093/annonc/mdu520. Epub 2014 Nov 13.
3
Long-term outcome of patients with clinical stage I high-risk nonseminomatous germ-cell tumors 15 years after one adjuvant cycle of bleomycin, etoposide, and cisplatin chemotherapy.临床Ⅰ期高危非精原细胞瘤生殖细胞肿瘤患者在接受博来霉素、依托泊苷和顺铂化疗 1 个辅助周期后 15 年的长期结果。
Ann Oncol. 2015 Feb;26(2):374-7. doi: 10.1093/annonc/mdu518. Epub 2014 Nov 12.
4
Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.睾丸高危临床I期非精原细胞瘤患者接受1周期博来霉素、依托泊苷和顺铂辅助化疗的长期随访结果
J Urol. 2008 Jan;179(1):163-6. doi: 10.1016/j.juro.2007.08.172. Epub 2007 Nov 14.
5
Re: The 111 Study: A Single-arm, Phase 3 Trial Evaluating One Cycle of Bleomycin, Etoposide, and Cisplatin as Adjuvant Chemotherapy in High-risk, Stage 1 Nonseminomatous or Combined Germ Cell Tumours of the Testis.回复：111研究：一项单臂3期试验，评估博来霉素、依托泊苷和顺铂的一个周期作为高危I期睾丸非精原细胞瘤或混合性生殖细胞肿瘤辅助化疗的疗效。
Eur Urol. 2021 Jan;79(1):160-161. doi: 10.1016/j.eururo.2020.08.010. Epub 2020 Nov 20.
6
Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.德国睾丸癌研究组进行的AUO试验AH 01/94：一项随机III期试验，比较腹膜后淋巴结清扫术与博来霉素、依托泊苷联合顺铂化疗一个疗程在临床I期非精原性睾丸生殖细胞肿瘤辅助治疗中的效果。
J Clin Oncol. 2008 Jun 20;26(18):2966-72. doi: 10.1200/JCO.2007.12.0899. Epub 2008 May 5.
7
Adjuvant chemotherapy for stage II nonseminomatous germ cell tumors.II期非精原细胞瘤性生殖细胞肿瘤的辅助化疗
Urol Clin North Am. 2007 May;34(2):179-85; abstract ix. doi: 10.1016/j.ucl.2007.02.005.
8
The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.播散性睾丸非精原细胞瘤的化疗及欧洲癌症研究与治疗组织泌尿生殖组的临床研究
Prog Clin Biol Res. 1985;203:437-47.
9
Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.接受依托泊苷和顺铂辅助化疗的病理II期非精原性生殖细胞癌患者的无复发生存率和总生存率。
J Clin Oncol. 2004 Feb 1;22(3):464-7. doi: 10.1200/JCO.2004.07.178.
10
[Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].改良腹膜后淋巴结清扫术治疗睾丸非精原细胞性生殖细胞肿瘤的疗效
Ai Zheng. 2008 Dec;27(12):1302-6.

引用本文的文献

1
Cancer Stemness Associated With Prognosis and the Efficacy of Immunotherapy in Adrenocortical Carcinoma.癌症干性与肾上腺皮质癌的预后及免疫治疗疗效的相关性
Front Oncol. 2021 Jul 21;11:651622. doi: 10.3389/fonc.2021.651622. eCollection 2021.
2
Reply to L.H. Einhorn et al.致L.H. 艾因霍恩等人的回复
J Clin Oncol. 2020 Sep 10;38(26):3074-3075. doi: 10.1200/JCO.20.01339. Epub 2020 Jul 7.